Skip to content
Bomb Report – Lifestyle
Author:
Xilio Therapeutics, Inc.
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
March 12, 2026
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
March 6, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 6, 2026
←
Previous Page
1
2